Outcomes of Hepatitis C Virus Treatment with Ledipasvir/Sofosbuvir in Mongolian Population: Successes and Challenges Facing Scale-up of Care

2017, Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study, 161

10.1016/j.jhep.2018.05.011

2018, EASL Recommendations on Treatment of Hepatitis C 2018, 461

Ghany, 2020, Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection, 686

Asahina, 2020, Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: integrated analysis of three clinical trials, 1109

10.3350/cmh.2020.0023

10.1016/j.jhep.2017.01.007

HARVONI prescribing information

2020, EASL recommendations on treatment of hepatitis C: final update of the series☆, 1170

10.1007/s10620-014-3361-6

10.5009/gnl17298

2016,

10.3350/cmh.2020.0018